T +1 212 819 8402
Mecaila Chapman is an associate in White & Case's Mergers & Acquisitions group, based in New York. Her practice focuses on the representation of corporate clients and private equity funds in connection with domestic and global mergers, acquisitions and equity investments in a broad range of industries. Prior to joining White & Case, she worked as a senior associate at a leading Australian law firm where her practice focused on private mergers and acquisitions and general corporate and securities law.
Pilot Flying J, the largest operator of travel centers in North America, and its shareholders, the Haslam Family, in the investment in a significant minority stake by Warren Buffet's Berkshire Hathaway.
CapGemini in its pending acquisition of the commercial cybersecurity division of Leidos.
Beal Bank in the acquisition, through its subsidiary CXA La Paloma, LLC, of all right, title and interest in a natural gas-fired, combined cycle electric generating facility consisting of four identical power blocks, located on an approximately 400-acre site in McKittrick, California, with a nameplate generating capacity of 1,200 MWC from La Paloma Generating Company, LLC, and CEP La Paloma Operating Company, LLC.
Harvest Partners in the acquisition of PRO Unlimited, a provider of contingent workforce management services and software.
Nature's Trees, Inc., a leading provider of quality tree, shrub and lawn care services, in connection with a majority equity investment in SavATree by an affiliate of CI Capital Partners.
Elliott Management Corporation and Franklin Mutual Advisers as noteholders of three outstanding series of notes of Affinion Group Holdings, Inc. and its subsidiaries, Affinion Group, Inc. and Affinion Investments, LLC.
VisioCap, LLC in its acquisition of a controlling interest in in Nature's Logic™, a premium, all natural pet food company based in Lincoln, Nebraska.
Roivant Sciences Ltd., a biopharmaceutical drug development company, in its US$116.4 million investment of convertible series A preferred shares in Arbutus Biopharma Corporation, an industry leading hepatitis B virus therapeutic solutions company.